Bulk Suggestion Bulk ID: cthulhudagod/11.21.24-08:40PM
Rejected at: Feb, 23, 2025 3:59 a.m.
Author: cthulhudagod
Related Deck: 1675118865074
Rejected
Rationale for new note

DVT - added cards for proximal

Rejection reason

Duplicate note. See note ID:
1698987905849.

Text
Text
What is the recommended management and duration for a <u>unprovoked</u>&nbsp;<b>proximal DVT</b>?&nbsp;<br><br>{{c1::DOAC (e.g. apixaban) for 3-6 months, followed by consideration of extended therapy}}
Extra
Extra
<img src="b365bc4eb448b2c68c6fa948fc57641b.webp"><br><br>Do not use apixaban if CrCL &lt;25mL/min
Extra (Synced)
Empty field
Extra (Synced)
Personal Notes
Empty field
Personal Notes
Missed Questions
Empty field
Missed Questions
eTG Complete
Empty field
eTG Complete
Talley & O'Connor
Empty field
Talley & O'Connor
Additional Resources
Empty field
Additional Resources
Additional Resources (Synced)
Empty field
Additional Resources (Synced)
Source
Source
eTG Complete Venous thromboembolism (VTE) treatment&nbsp;<a href="https://tgldcdp-tg-org-au.eu1.proxy.openathens.net/viewTopic?etgAccess=true&amp;guidelinePage=Cardiovascular&amp;topicfile=cardiovascular-disease-risk-stratification&amp;guidelinename=auto%C2%A7ionId=c_CVG_Venous-thromboembolism-treatmenttopic_14#c_CVG_Venous-thromboembolism-treatmenttopic_14">https://tgldcdp-tg-org-au.eu1.proxy.openathens.net/viewTopic?etgAccess=true&amp;guidelinePage=Cardiovascular&amp;topicfile=cardiovascular-disease-risk-stratification&amp;guidelinename=auto&amp;sectionId=c_CVG_Venous-thromboembolism-treatmenttopic_14#c_CVG_Venous-thromboembolism-treatmenttopic_14</a>&nbsp;Accessed 22 November 2024.<br><br><a href="https://emedici.com/app/share/question/1150">https://emedici.com/app/share/question/1150</a>
One by one
Empty field
One by one
Tags
#Malleus_CM::#Resources_by_Rotation::Internal_Medicine::Cardiology #Malleus_CM::#Subjects::Cardiology::13_Vascular_Pathology::Peripheral_Vascular_Pathology::Deep_Vein_Thrombosis::10_Management #Malleus_CM::#Yield::High